Your browser doesn't support javascript.
loading
Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations: An Analysis From the RAIN-CARDIOGROUP VII Study.
Gaido, Luca; D'Ascenzo, Fabrizio; Imori, Yoichi; Wojakowski, Wojciech; Saglietto, Andrea; Figini, Filippo; Mattesini, Alessio; Trabattoni, Daniela; Rognoni, Andrea; Tomassini, Francesco; Bernardi, Alessandro; Ryan, Nicola; Muscoli, Saverio; Helft, Gerard; De Filippo, Ovidio; Parma, Radoslaw; De Luca, Leonardo; Ugo, Fabrizio; Cerrato, Enrico; Montefusco, Antonio; Pennacchi, Mauro; Wanha, Wojciech; Smolka, Grzegorz; de Lio, Giulia; Bruno, Francesco; Huczek, Zenon; Boccuzzi, Giacomo; Cortese, Bernardo; Capodanno, Davide; Omedè, Pierluigi; Mancone, Massimo; Nuñez-Gil, Ivan; Romeo, Francesco; Varbella, Ferdiando; Rinaldi, Mauro; Escaned, Javier; Conrotto, Federico; Burzotta, Francesco; Chieffo, Alaide; Perl, Leor; D'Amico, Maurizio; di Mario, Carlo; Sheiban, Imad; Gagnor, Andrea; Giammaria, Massimo; De Ferrari, Gaetano Maria.
Afiliação
  • Gaido L; Division of Cardiology, Ospedale Maria Vittoria, Turin (L.G., A.G., M.G.).
  • D'Ascenzo F; Division of Cardiology, Department of Medical Science, Città della Salute e della Scienza, Turin (F.D., A.S., F.F., A. Montefusco, G.d.L., F.B., P.O., M.R., F.C., M.D., G.M.D.F.).
  • Imori Y; Department of Cardiovascular Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, Japan (Y.I.).
  • Wojakowski W; Department of Cardiology, Medical University of Silesia, Katowice, Poland (W. Wojakowski, W. Wanha, G.S.).
  • Figini F; Division of Cardiology, Department of Medical Science, Città della Salute e della Scienza, Turin (F.D., A.S., F.F., A. Montefusco, G.d.L., F.B., P.O., M.R., F.C., M.D., G.M.D.F.).
  • Mattesini A; Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy (A. Mattesini, C.d.M.).
  • Trabattoni D; Department of Cardiovascular Sciences, IRCCS Centro Cardiologico Monzino, University of Milan, Italy (D.T.).
  • Rognoni A; Coronary Care Unit and Catheterization laboratory, A.O.U. Maggiore della Carità, Novara, Italy (A.R.).
  • Tomassini F; Department of Cardiology, Infermi Hospital, Rivoli, Italy (F.T., E.C., F.V.).
  • Bernardi A; Department of Cardiology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy (F.T., E.C., F.V.).
  • Ryan N; Dipartimento di Cardiologia, Ospedale San Giovanni Bosco, Italy (A.B., F.U., G.B.).
  • Muscoli S; Department of Cardiology, Hospital Clinico San Carlos, Madrid, Spain (N.R., I.N.-G., J.E.).
  • Helft G; Department of Medicine, Università degli Studi di Roma 'Tor Vergata', Rome, Italy (S.M., F.R.).
  • De Filippo O; Pierre and Marie Curie University, Paris, France (G.H.).
  • De Luca L; University Clinical Hospital, Warsaw, Poland (R.P., Z.H.).
  • Ugo F; Division of Cardiology, S. Giovanni Evangelista Hospital, Tivoli, Rome, Italy (L.D.L., M.P.).
  • Cerrato E; Dipartimento di Cardiologia, Ospedale San Giovanni Bosco, Italy (A.B., F.U., G.B.).
  • Montefusco A; Department of Cardiology, Infermi Hospital, Rivoli, Italy (F.T., E.C., F.V.).
  • Pennacchi M; Department of Cardiology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy (F.T., E.C., F.V.).
  • Wanha W; Division of Cardiology, Department of Medical Science, Città della Salute e della Scienza, Turin (F.D., A.S., F.F., A. Montefusco, G.d.L., F.B., P.O., M.R., F.C., M.D., G.M.D.F.).
  • Smolka G; Division of Cardiology, S. Giovanni Evangelista Hospital, Tivoli, Rome, Italy (L.D.L., M.P.).
  • de Lio G; Department of Cardiology, Medical University of Silesia, Katowice, Poland (W. Wojakowski, W. Wanha, G.S.).
  • Bruno F; Department of Cardiology, Medical University of Silesia, Katowice, Poland (W. Wojakowski, W. Wanha, G.S.).
  • Huczek Z; Division of Cardiology, Department of Medical Science, Città della Salute e della Scienza, Turin (F.D., A.S., F.F., A. Montefusco, G.d.L., F.B., P.O., M.R., F.C., M.D., G.M.D.F.).
  • Boccuzzi G; Division of Cardiology, Department of Medical Science, Città della Salute e della Scienza, Turin (F.D., A.S., F.F., A. Montefusco, G.d.L., F.B., P.O., M.R., F.C., M.D., G.M.D.F.).
  • Cortese B; University Clinical Hospital, Warsaw, Poland (R.P., Z.H.).
  • Capodanno D; Dipartimento di Cardiologia, Ospedale San Giovanni Bosco, Italy (A.B., F.U., G.B.).
  • Omedè P; San Carlo Clinic, Milano, Italy (B.C.).
  • Mancone M; Division of Cardiology, Cardio-Thoracic-Vascular Department, Azienda Ospedaliero Universitaria "Policlinico-Vittorio Emanuele," Catania, Italy (D.C.).
  • Nuñez-Gil I; Division of Cardiology, Department of Medical Science, Città della Salute e della Scienza, Turin (F.D., A.S., F.F., A. Montefusco, G.d.L., F.B., P.O., M.R., F.C., M.D., G.M.D.F.).
  • Romeo F; Università degli Studi di ROMA "La Sapienza" (M.M.), Lazio, Italia.
  • Varbella F; Department of Cardiology, Hospital Clinico San Carlos, Madrid, Spain (N.R., I.N.-G., J.E.).
  • Rinaldi M; Department of Medicine, Università degli Studi di Roma 'Tor Vergata', Rome, Italy (S.M., F.R.).
  • Escaned J; Department of Cardiology, Infermi Hospital, Rivoli, Italy (F.T., E.C., F.V.).
  • Conrotto F; Department of Cardiology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy (F.T., E.C., F.V.).
  • Burzotta F; Division of Cardiology, Department of Medical Science, Città della Salute e della Scienza, Turin (F.D., A.S., F.F., A. Montefusco, G.d.L., F.B., P.O., M.R., F.C., M.D., G.M.D.F.).
  • Chieffo A; Department of Cardiology, Hospital Clinico San Carlos, Madrid, Spain (N.R., I.N.-G., J.E.).
  • Perl L; Division of Cardiology, Department of Medical Science, Città della Salute e della Scienza, Turin (F.D., A.S., F.F., A. Montefusco, G.d.L., F.B., P.O., M.R., F.C., M.D., G.M.D.F.).
  • D'Amico M; Università Cattolica del Sacro Cuore Roma (F.B.), Lazio, Italia.
  • di Mario C; San Raffaele Scientific Institute, Milan, Italy (A.C.).
  • Sheiban I; Rabin Medical Center, Department of Cardiology, Tel Aviv, Israel (L.P.).
  • Gagnor A; Division of Cardiology, Department of Medical Science, Città della Salute e della Scienza, Turin (F.D., A.S., F.F., A. Montefusco, G.d.L., F.B., P.O., M.R., F.C., M.D., G.M.D.F.).
  • Giammaria M; Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy (A. Mattesini, C.d.M.).
  • De Ferrari GM; Pederzoli Hospital, Peschiera del Garda, Italy (I.S.).
Circ Cardiovasc Interv ; 13(3): e008325, 2020 03.
Article em En | MEDLINE | ID: mdl-32102566
BACKGROUND: There are limited data regarding the impact of final kissing balloon (FKI) in patients treated with percutaneous coronary intervention using ultrathin stents in left main or bifurcations. METHODS: All patients undergoing left main or bifurcations percutaneous coronary intervention enrolled in the RAIN registry (Very Thin Stents for Patients With MAIN or BiF in Real Life: The RAIN, a Multicenter Study) evaluating ultrathin stents were included. Major adverse cardiac event (a composite of all-cause death, myocardial infarction, target lesion revascularization, and stent thrombosis) was the primary end point, while its components, along with target vessel revascularization, were the secondary end points. The main analysis was performed comparing patients with and without FKI after adjustment with inverse probability of treatment weighting. Subgroup analyses were performed according to FKI (short [<3 mm] versus long overlap), strategy (provisional versus 2-stent), routine versus bail-out FKI, and the use of imaging and proximal optimization technique. RESULTS: Two thousand seven hundred forty-two patients were included. At 16 months (8-20) follow-up, inverse probability of treatment weighting adjusted rates of major adverse cardiac event were similar between FKI and no-FKI group (15.1% versus 15.5%; P=0.967), this result did not change with use of imaging, proximal optimization technique, or routine versus bail-out FKI. In the 2-stent subgroup, FKI was associated with lower rates of target vessel revascularization (7.8% versus 15.9%; P=0.030) and target lesion revascularization (7.3% versus 15.2%; P=0.032). Short overlap FKI was associated with a lower rate of target lesion revascularization compared with no FKI (2.6% versus 5.4%; P=0.034), while long overlap was not (6.8% versus 5.4%; P=0.567). CONCLUSIONS: In patients with bifurcations or unprotected left main treated with ultrathin stents, short overlap FKI is associated with less restenosis. In a 2-stent strategy, FKI was associated with less target vessel revascularization and restenosis. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03544294.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Prótese / Doença da Artéria Coronariana / Angioplastia Coronária com Balão / Stents Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Circ Cardiovasc Interv Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Prótese / Doença da Artéria Coronariana / Angioplastia Coronária com Balão / Stents Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Circ Cardiovasc Interv Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2020 Tipo de documento: Article